Ketoconazole in Treating Participants With Ongoing EGFR Inhibitor-Induced Rash

Summary

This early phase I trial studies the side effects of ketoconazole and how well it works in treating participants with ongoing EGFR inhibitor-induced rash. Ketoconazole may reduce the symptoms related to EGFR inhibitor therapy and improve EGFR inhibitor-induced rash.

Timeline

Start

2018-09-25

Primary completion

2024-09-15

Completion

2024-09-15

Drugs

Indications